Leerink Partners Upgrades Gossamer Bio Stock Rating Amid Institutional Buying
1 report, 1 independent
Updated Sat 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink Partners upgraded Gossamer Bio stock rating on September 26, 2026. Separately, institutional investors have shown significant buying interest in Gossamer Bio, with Hsbc Holdings PLC increasing its holdings by 1,289.4% during the second quarter.
From tickerreport.com
Why it matters
The analyst upgrade, alongside substantial institutional accumulation, suggests increased investor confidence in Gossamer Bio. This positive market signal could intensify competitive pressure on Candel Therapeutics.
From tickerreport.com
Who's involved
- Leerink partnersU.S. investment bank that upgraded the stock rating
Keep exploring
The entities involved
-
Leerink partners
U.S. investment bank